Who is sponsoring NCT06128057?

NCT06128057 is sponsored by Assiut University.

What drugs are being tested in NCT06128057?

Interventions in NCT06128057: Blood products.

What condition does NCT06128057 study?

NCT06128057 studies Massive Blood Transfusion in Trauma Patients.

Is NCT06128057 still recruiting?

NCT06128057 is currently status unknown. Last updated 13 November 2023.

Last reviewed 2023-11-13 · How we verify

NCT06128057

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparing TASH Score and Modified TBSS in Trauma Patients in Need for Massive Blood Transfusion

Status unknown Last updated 13 November 2023

What this trial tests

trial testing Blood products in Massive Blood Transfusion in Trauma Patients in 140 participants. Status unknown.

Timeline

5 December 2023

Primary endpoint
5 July 2025

10 November 2025

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	140
Start date	5 December 2023
Primary completion	5 July 2025
Estimated completion	10 November 2025

Drugs / interventions tested

Blood products — full drug profile →

Conditions studied

Massive Blood Transfusion in Trauma Patients — all drugs for Massive Blood Transfusion in Trauma Patients →

Sponsor

Assiut University

Who can join

18 and older, any sex, with Massive Blood Transfusion in Trauma Patients. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Evaluate And Compare predictive value of TASH Score And MTBBS In need for Massive Blood Transfusion

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Blood products

Trials testing the same drug.

NCT04879485 — Prehospital Transfusion Strategy in Bleeding Patients · NA · completed

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06128057 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 13 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06128057.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing